BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7905185)

  • 1. [Early evening and late evening administration of roxatidine acetate in therapy of duodenal ulcer].
    Bosseckert H; Ernst R; Kriech W; Schunter C
    Med Klin (Munich); 1993 Nov; 88(11):637-41. PubMed ID: 7905185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roxatidine versus ranitidine in the treatment of duodenal ulcer: a randomized, double blind, controlled, multicenter study in Thailand.
    Kachintorn U; Chinapak O; Vongphanich V; Kositchaiwat C; Lekhayananda S; Khow-ean U; Suttinont C; Saowaros V; Kludchareon N; Leethochawalit M
    J Med Assoc Thai; 1995 Dec; 78(12):641-7. PubMed ID: 8868007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roxatidine in duodenal ulcer.
    Habibullah CM; Habeeb MA; Singh SP
    J Postgrad Med; 1995; 41(3):64-5. PubMed ID: 10707717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter, double-blind, randomized, placebo-controlled comparison of nocturnal roxatidine in the treatment of active duodenal ulcer disease. Multicenter Roxatidine Cooperative Study Group.
    Gilinsky NH; Bright-Asare P; Cobert BL; Fitch DD; Lanza FL; Kerr RM; Savitsky JP
    Am J Gastroenterol; 1992 Jul; 87(7):847-53. PubMed ID: 1352083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roxatidine acetate as maintenance treatment for patients with peptic ulcer disease. The European Cooperative Roxatidine Study Group.
    Clin Ther; 1991; 13(1):47-57. PubMed ID: 1674231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Early evening administration of ranitidine in therapy of duodenal ulcer].
    Schmidtke-Schrezenmeier G; Klingmann J; Pabst G; Geerke H; Koch EM
    Z Gastroenterol; 1990 Dec; 28(12):656-9. PubMed ID: 2087820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty-four-hour intragastric acidity following early evening or bedtime administration of roxatidine in duodenal ulcer patients.
    Lazzaroni M; Sangaletti O; Bargiggia S; Bensi G; Canali A; Bianchi Porro G
    Aliment Pharmacol Ther; 1996 Apr; 10(2):187-91. PubMed ID: 8730248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Circadian aspects of diclofenac gastroduodenopathy and the protective effect of roxatidine].
    Müller P; Jackisch P; Simon B
    Z Rheumatol; 1993; 52(5):297-300. PubMed ID: 7903132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The histological maturity of regenerating mucosa of healed duodenal ulcer and ulcer recurrence after treatment with H2-antagonist.
    Pan S; Liao CH
    Am J Gastroenterol; 1990 Aug; 85(8):949-52. PubMed ID: 1973870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roxatidine versus ranitidine in the treatment of patients with duodenal ulcer: a randomized, double-masked, multicenter study.
    Zuberi SJ; Khan AQ; Irshad-ul-Haque I; Hussain A; Hasnain SS; Shah S; Sadick A; Yusuf MZ; Reuter M
    Clin Ther; 1996; 18(6):1207-12. PubMed ID: 9001837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of roxatidine acetate 150 mg once daily and 75 mg twice daily in duodenal ulcer healing.
    Hentschel E; Schütze K
    Drugs; 1988; 35 Suppl 3():96-101. PubMed ID: 2905256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New H2-receptor antagonist--roxatidine acetate--in treatment of duodenal ulcer.
    Amarapurkar DN; Parikh SS; Desai HG
    J Assoc Physicians India; 1993 Aug; 41(8):496-7. PubMed ID: 7904993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy and safety of ebrotidine in the treatment of duodenal ulcer. A multicentre, double-blind, placebo-controlled phase II study.
    Gabryelewicz A; Czajkowski A; Skrodzka D; Marlicz K; Luca de Tena F; Aldeguer M; Chantar C; Márquez M; Torres J; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):545-50. PubMed ID: 9205762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ranitidine in stomach ulcer. Controlled clinical trial of a comparison of administration after the evening meal or before bedtime].
    Brinkhoff H; Köhler CO; Koch EM
    Fortschr Med; 1990 Jun; 108(17):343-6. PubMed ID: 2198208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roxatidine versus ranitidine in the treatment of duodenal ulcers: a randomized double-blind controlled multicentre study in Singapore.
    Fock KM; Kang JY; Ng HS; Ng TM; Gwee KA; Lim CC
    J Gastroenterol Hepatol; 1995; 10(4):379-82. PubMed ID: 8527701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiographic assessment of nocturnal gastric juice secretion after administration of roxatidine acetate hydrochloride.
    Tanioka H; Terahara A; Sasaki Y
    Clin Ther; 1991; 13(1):22-4. PubMed ID: 1674230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine.
    Savarino V; Mela GS; Zentilin P; Cutela P; Vigneri S; Termini R; Di Mario F; Ferrana M; Malesci A; Belicchi M; Celle G
    Fundam Clin Pharmacol; 1996; 10(3):304-8. PubMed ID: 8836705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of roxatidine acetate and ranitidine in duodenal ulcer healing.
    Hüttemann W
    Drugs; 1988; 35 Suppl 3():90-5. PubMed ID: 2905255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of roxatidine acetate and ranitidine in the treatment of reflux esophagitis. The Roxatidine Esophagitis Study Group.
    Clin Ther; 1993; 15(2):283-93. PubMed ID: 8100189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roxatidine acetate in the long term maintenance of duodenal ulcers.
    Brunner G
    Drugs; 1988; 35 Suppl 3():102-5. PubMed ID: 2905238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.